18th May 2020 15:39
(Alliance News) - N4 Pharma PLC on Monday said it will file patents for its Nuvec delivery system in major markets across the world.
The pharmaceutical company said it is filing patent applications in Europe, the UK, the US, Japan, India, Australia, Canada, and China
In 2018, N4 Pharma filed a patent cooperation treaty application for improvements made to the manufacturing process for its Nuvec system.
Under the terms of the application process, and following conclusion of the national phasing, the company is required to make specific applications in the territories in which it wishes to gain patent protection, N4 explained.
"We are seeking additional protection in the territories listed above, which the board believes would provide maximum patent coverage for our PCT application whilst minimising outgoing expenditure. If the patents are granted in these regions, the company will maintain its strong commercial protection of Nuvec," said Chief Executive Nigel Theobald.
The stock was trading 6.4% higher at 5.05 pence each on Monday afternoon in London.
By Ife Taiwo; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
N4 Pharma Plc